Eaton Vance Worldwide Health Sciences Fund Bolsters Position in IDEXX Laboratories - Yahoo Finance UK
| 0J8P Stock | 416.54 3.95 0.96% |
Slightly above 52% of IDEXX Laboratories' investor base is interested to short. The analysis of overall sentiment of trading IDEXX Laboratories stock suggests that many investors are impartial at this time. IDEXX Laboratories' investing sentiment can be driven by a variety of factors including economic data, IDEXX Laboratories' earnings reports, geopolitical events, and overall market trends.
IDEXX Laboratories stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of IDEXX daily returns and investor perception about the current price of IDEXX Laboratories as well as its diversification or hedging effects on your existing portfolios.
IDEXX |
Eaton Vance Worldwide Health Sciences Fund Bolsters Position in IDEXX Laboratories Yahoo Finance UK
Read at news.google.com
 |
IDEXX Laboratories Fundamental Analysis
We analyze IDEXX Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
IDEXX Laboratories is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
IDEXX Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IDEXX Laboratories stock to make a market-neutral strategy. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with similar companies.
Peers
IDEXX Laboratories Related Equities
| MUL | Mulberry Group | 7.00 | ||||
| LSC | London Security | 0.00 | ||||
| IKIV | Ikigai Ventures | 0.00 | ||||
| HVT | Heavitree Brewery | 0.00 | ||||
| 0RJ4 | Uniper SE | 1.03 | ||||
| TRD | Triad Group | 1.75 | ||||
| STK | SURETRACK MON | 2.78 |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.